{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:08:40Z","timestamp":1780463320290,"version":"3.54.1"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006321","name":"National Institutes of Natural Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) is a growing global health issue, chiefly marked by inexorable myocyte loss, maladaptive remodeling, and energetic failure. MicroRNAs (miRNAs) function as the principal post-transcriptional regulators of gene networks capable of facilitating the pathophysiology of illnesses. However, there is limited systemic-level understanding of their participation in human HF. Therefore, the miRNA mechanisms that modulate apoptosis, autophagy, myocardial fibrosis, inflammatory response, and energy metabolism of cardiomyocytes to inhibit and treat HF are elucidated in this work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A analysis of the mechanisms utilized by miRNAs in the modulation of HF was performed following the retrieval of literature on the mechanism of action of miRNAs in HF. The literature was obtained from PubMed and Web of Science databases between 2021 and 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The multi-dimensional regulatory function of miRNAs in HF was uncovered. At the cellular fate level, they mediate the survival and death of the myocardium and inhibit excessive apoptosis and oxidative damage. At the organizational structure level, they inhibit the advancement of pathological ventricular remodeling and fibrosis. At the energy homeostasis level, they control autophagy and energy metabolism of cells. Finally, at the inflammatory and signaling levels, they suppress the inflammatory storm and maintain calcium signaling homeostasis. A sophisticated and dynamic regulatory system consisting of various miRNAs was observed, which offers a theoretical basis and potential targets for HF mechanism research and targeted intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MicroRNAs (miRNAs) jointly affect the survival, remodeling and energy balance of cardiac muscle cells. However, the clinical application of miRNAs in HF is still in the early exploration stage, and their true diagnostic value and therapeutic potential need to be further confirmed by rigorous and large-scale clinical studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1753834","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:54:22Z","timestamp":1780462462000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The pathophysiological role of MiRNAs in heart failure"],"prefix":"10.3389","volume":"13","author":[{"given":"Kun","family":"Lian","sequence":"first","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qi","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichong","family":"Meng","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichang","family":"Xu","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Song","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixi","family":"Hu","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jacasi.2024.01.013","article-title":"Epidemiology and Burden of Heart Failure in Asia","volume":"4","author":"Feng","year":"2024","journal-title":"JACC Asia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10741-020-09987-z","article-title":"Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers","volume":"27","author":"Triposkiadis","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ehf2.14153","article-title":"MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure-a review","volume":"10","author":"Gargiulo","year":"2023","journal-title":"ESC Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-physiol-030212-183737","article-title":"Functions of microRNAs in cardiovascular biology and disease","volume":"75","author":"Hata","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1007\/s11033-023-08695-9","article-title":"miRNA as biomarker in lung cancer","volume":"50","author":"Lobera","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.07.003","article-title":"MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance","volume":"70","author":"Iqbal","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11033-022-07995-w","article-title":"Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer","volume":"50","author":"Rajakumar","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11883-024-01216-4","article-title":"Unraveling the miRNA puzzle in atherosclerosis: revolutionizing diagnosis, prognosis, and therapeutic approaches","volume":"26","author":"Abulsoud","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Martino","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and cardiovascular disease risk","volume":"26","author":"Searles","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11033-025-10436-z","article-title":"Targeted miRNA delivery in epilepsy: mechanisms, advances, and therapeutic potential","volume":"52","author":"Shyam","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00380-022-02231-8","article-title":"MiR-568 mitigated cardiomyocytes apoptosis, oxidative stress response and cardiac dysfunction via targeting SMURF2 in heart failure rats","volume":"38","author":"Zhang","year":"2023","journal-title":"Heart Vessels"},{"key":"B15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat Rev Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2006.03.043","article-title":"Molecular basis for the recognition of primary microRNAs by the drosha-DGCR8 complex","volume":"125","author":"Han","year":"2006","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.1090599","article-title":"Nuclear export of microRNA precursors","volume":"303","author":"Lund","year":"2004","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41586-023-05723-3","article-title":"Structure of the human DICER-pre-miRNA complex in a dicing state","volume":"615","author":"Lee","year":"2023","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1101\/gr.251421.119","article-title":"Global analyses of the dynamics of mammalian microRNA metabolism","volume":"29","author":"Kingston","year":"2019","journal-title":"Genome Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","article-title":"Secreted microRNAs: a new form of intercellular communication","volume":"22","author":"Chen","year":"2012","journal-title":"Trends Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2020.12.025","article-title":"Dissecting miRNA signature in colorectal cancer progression and metastasis","volume":"501","author":"Huang","year":"2021","journal-title":"Cancer Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12051","DOI":"10.1002\/jev2.12051","article-title":"Cdc42 functions as a regulatory node for tumour-derived microvesicle biogenesis","volume":"10","author":"Wang","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/mutage\/gez038","article-title":"Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review","volume":"35","author":"Francavilla","year":"2020","journal-title":"Mutagenesis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"eabc9546","DOI":"10.1126\/science.abc9546","article-title":"A ubiquitin ligase mediates target-directed microRNA decay independently of tailing and trimming","volume":"370","author":"Han","year":"2020","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eabc9359","DOI":"10.1126\/science.abc9359","article-title":"The ZSWIM8 ubiquitin ligase mediates target-directed microRNA degradation","volume":"370","author":"Shi","year":"2020","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/FJC.0000000000001588","article-title":"Research progress of miRNA in heart failure: prediction and treatment","volume":"84","author":"Hou","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/cells10113191","article-title":"A review on the evolving roles of MiRNA-based technologies in diagnosing and treating heart failure","volume":"10","author":"Kennel","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"117716","DOI":"10.1016\/j.biopha.2024.117716","article-title":"Resveratrol alleviates heart failure by activating foxo3a to counteract oxidative stress and apoptosis","volume":"181","author":"Liu","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1038\/s41598-020-63090-9","article-title":"Qi Dan Li Xin pill improves chronic heart failure by regulating mTOR\/p70S6k-mediated autophagy and inhibiting apoptosis","volume":"10","author":"Shi","year":"2020","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/kjm2.12740","article-title":"Dioscin ameliorates doxorubicin-induced heart failure via inhibiting autophagy and apoptosis by controlling the PDK1-mediated Akt\/mTOR signaling pathway","volume":"39","author":"Yuan","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/antiox11020336","article-title":"The role of oxidative stress in the aging heart","volume":"11","author":"Pagan","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2018.09.019","article-title":"Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities","volume":"129","author":"Kiyuna","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3946320251315800","DOI":"10.1177\/03946320251315800","article-title":"Baicalein protects against heart failure by improving mitochondrial dysfunction and regulating endoplasmic reticulum stress to reduce apoptosis in vitro and in vivo","volume":"39","author":"Zhang","year":"2025","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.22038\/IJBMS.2023.66481.14589","article-title":"Icariin ameliorates oxidative stress-induced inflammation, apoptosis, and heart failure in isoproterenol-challenged wistar rats","volume":"26","author":"Sharma","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000445631","article-title":"Modulation of MAPK and NF-954;B signaling pathways by antioxidant therapy in skeletal muscle of heart failure rats","volume":"39","author":"Martinez","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"9829505","DOI":"10.1155\/2022\/9829505","article-title":"Oxidative stress and heart failure: mechanisms, signalling pathways, and therapeutics","volume":"2022","author":"Pagan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"102921","DOI":"10.1016\/j.tice.2025.102921","article-title":"MiR-1 alleviates chronic heart failure through HCN2\/HCN4 axis in vitro","volume":"95","author":"Luo","year":"2025","journal-title":"Tissue Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.23812\/j.biol.regul.homeost.agents.20233703.138","article-title":"miR-18a-5p overexpression improves cardiac function and inhibits cardiomyocyte apoptosis through the notch signaling pathway in chronic heart failure rats","volume":"37","author":"Xu","year":"2023","journal-title":"J Biol Regul Homeost Agents"},{"key":"B50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/cbdd.14142","article-title":"MiR-22-3p in exosomes increases the risk of heart failure after down-regulation of FURIN","volume":"101","author":"Lu","year":"2023","journal-title":"Chem Biol Drug Des"},{"key":"B51","doi-asserted-by":"publisher","first-page":"111407","DOI":"10.1016\/j.cellsig.2024.111407","article-title":"MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1\/PI3K signaling pathway","volume":"124","author":"Zheng","year":"2024","journal-title":"Cell Signal"},{"key":"B52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/tjb-2025-0033","article-title":"miR-30c-5p serves a diagnostic biomarker in chronic heart failure patients and its regulatory role in vascular endothelial","volume":"51","author":"Xiong","year":"2026","journal-title":"Turk J Biochem-Turk Biyokimya Dergisi"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e22937","DOI":"10.1096\/fj.202202148RR","article-title":"ETS2 Promotes cardiomyocyte apoptosis and autophagy in heart failure by regulating lncRNA TUG1\/miR-129-5p\/ATG7 axis","volume":"37","author":"Tan","year":"2023","journal-title":"FASEB J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1080\/21655979.2021.2024335","article-title":"miR-129-5p restores cardiac function in rats with chronic heart failure by targeting the E3 ubiquitin ligase Smurf1 and promoting PTEN expression","volume":"13","author":"Qi","year":"2022","journal-title":"Bioengineered"},{"key":"B55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/cbdd.14104","article-title":"Upregulation of miR-144-3p alleviates doxorubicin-induced heart failure and cardiomyocytes apoptosis via SOCS2\/PI3K\/AKT axis","volume":"101","author":"Zhang","year":"2023","journal-title":"Chem Biol Drug Des"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11596-025-00053-z","article-title":"Targeting miR-144-5p\/ACSM1 axis alleviates doxorubicin-induced heart failure by inhibiting lipid peroxidation","volume":"45","author":"Kao","year":"2025","journal-title":"Curr Med Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"20230146","DOI":"10.1515\/chem-2023-0146","article-title":"LncRNA MIR17HG alleviates heart failure via targeting MIR17HG\/miR-153-3p\/SIRT1 axis in in vitro model","volume":"22","author":"Sun","year":"2024","journal-title":"Open Chem"},{"key":"B58","first-page":"6425","article-title":"Up-regulation of miR-155 protects against chronic heart failure by inhibiting HIF-1\u03b1","volume":"15","author":"Luo","year":"2023","journal-title":"Am J Transl Res"},{"key":"B59","first-page":"146","article-title":"Efficacy of adenovirus-mediated, miR-199a nanoparticles on expression of HSP27, HSP70, and soluble glycoprotein in rats with heart failure","volume":"29","author":"Tan","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"526","DOI":"10.5114\/aoms.2020.94500","article-title":"MiR-200a promotes the survival of cardiac cells and improves cardiac injury in chronic heart failure rats","volume":"21","author":"Wu","year":"2025","journal-title":"Arch Med Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11010-022-04523-z","article-title":"A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p\/MAPK axis","volume":"478","author":"Wang","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13019-024-03221-9","article-title":"Effect of miR-1285-3p as a diagnostic biomarker for chronic heart failure on vascular endothelial cells: (effect of miR-1285-3p as a biomarker for CHF on HUVECs)","volume":"20","author":"Zhang","year":"2025","journal-title":"J Cardiothorac Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.23736\/S2724-5683.24.06596-7","article-title":"Upregulation of serum miR-4429 discriminates chronic heart failure patients and regulates cardiomyocyte injury via modulating HAPLN1","volume":"73","author":"Sun","year":"2025","journal-title":"Minerva Cardiol Angiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.mam.2023.101194","article-title":"Cardiac fibrosis in heart failure: focus on non-invasive diagnosis and emerging therapeutic strategies","volume":"93","author":"Ravassa","year":"2023","journal-title":"Mol Aspects Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCRESAHA.124.325402","article-title":"Cardiac fibrosis in the multi-omics era: implications for heart failure","volume":"136","author":"Ghazal","year":"2025","journal-title":"Circ Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the infarcted, remodeling, and failing heart","volume":"4","author":"Humeres","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tips.2017.03.001","article-title":"Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps","volume":"38","author":"Ma","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"7638","DOI":"10.1038\/s41467-024-52068-0","article-title":"Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion","volume":"15","author":"Yoshida","year":"2024","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"724147","DOI":"10.3389\/fphar.2021.724147","article-title":"Lcz696 alleviates myocardial fibrosis after myocardial infarction through the sFRP-1\/Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41401-021-00805-2","article-title":"Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress","volume":"43","author":"Ren","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B75","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jcmm.17081","article-title":"CaMKII inhibitor KN-93 impaired angiogenesis and aggravated cardiac remodelling and heart failure via inhibiting NOX2\/mtROS\/p-VEGFR2 and STAT3 pathways","volume":"26","author":"Ni","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","article-title":"Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation","volume":"12","author":"Hao","year":"2021","journal-title":"Cell Death Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"725186","DOI":"10.3389\/fphar.2021.725186","article-title":"Dangshen Erling decoction ameliorates myocardial hypertrophy via inhibiting myocardial inflammation","volume":"12","author":"Zhong","year":"2022","journal-title":"Front Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"905424","DOI":"10.3389\/fphar.2022.905424","article-title":"Qiliqiangxin modulates the gut microbiota and NLRP3 inflammasome to protect against ventricular remodeling in heart failure","volume":"13","author":"Lu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"707394","DOI":"10.3389\/fphar.2021.707394","article-title":"Traditional Chinese medicine intervenes ventricular remodeling following acute myocardial infarction: evidence from 40 random controlled trials with 3,659 subjects","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"695004","DOI":"10.3389\/fcvm.2022.695004","article-title":"Cardioprotective effect of paeonol on chronic heart failure induced by doxorubicin via regulating the miR-21-5p\/S-phase kinase-associated protein 2 axis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yjmcc.2024.11.004","article-title":"Inhibition of miR-92a normalizes vascular gene expression and prevents diastolic dysfunction in heart failure with preserved ejection fraction","volume":"198","author":"Kattih","year":"2025","journal-title":"J Mol Cell Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e18546","DOI":"10.1111\/jcmm.18546","article-title":"The role of miR-128 and MDFI in cardiac hypertrophy and heart failure: mechanistic","volume":"28","author":"Yanjun","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/15476278.2021.2020018","article-title":"Upregulation of miR-128 mediates heart injury by activating wnt\/\u03b2-catenin signaling pathway in heart failure mice","volume":"17","author":"Li","year":"2021","journal-title":"Organogenesis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/FJC.0000000000001729","article-title":"miR-132 inhibition improves cardiac remodeling and function in a two-hit mouse model of heart failure with a preserved ejection fraction","volume":"86","author":"Wu","year":"2025","journal-title":"J Cardiovasc Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/mmr.2021.12540","article-title":"Schisandrin A protects against isoproterenol-induced chronic heart failure via miR-155","volume":"25","author":"Gao","year":"2021","journal-title":"Mol Med Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"111818","DOI":"10.1016\/j.mad.2023.111818","article-title":"miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction","volume":"212","author":"Jankauskas","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1383046","DOI":"10.3389\/fcvm.2024.1383046","article-title":"Divergent cardiac and renal effects of miR-181c-5p inhibition in a rodent heart failure model","volume":"11","author":"Boen","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvad184","article-title":"miR-222 inhibits pathological cardiac hypertrophy and heart failure","volume":"120","author":"Liu","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e70199","DOI":"10.1111\/jcmm.70199","article-title":"Fibroblast-derived miR-425-5p alleviates cardiac remodelling in heart failure via inhibiting the TGF-\u03b21\/Smad signalling","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/cells11244020","article-title":"Kinetic mathematical modeling of oxidative phosphorylation in cardiomyocyte mitochondria","volume":"11","author":"Tseng","year":"2022","journal-title":"Cells"},{"key":"B91","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12967-025-06828-1","article-title":"Role of circadian rhythms in heart failure: insights from myocardial energy metabolism","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/CRD.0b013e318274956d","article-title":"Energy metabolism in cardiac remodeling and heart failure","volume":"21","author":"Azevedo","year":"2013","journal-title":"Cardiol Rev"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 Deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/jcdd10080352","article-title":"Autophagy in heart failure: insights into mechanisms and therapeutic implications","volume":"10","author":"Bielawska","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1871529X23666230503123612","article-title":"Autophagy behavior in post-myocardial infarction injury","volume":"23","author":"Marzoog","year":"2023","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The role of autophagy in the heart","volume":"80","author":"Sciarretta","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.3390\/ijms26199826","article-title":"Oxidative stress, mitochondrial quality control, autophagy, and sirtuins in heart failure","volume":"26","author":"Krekora","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.62347\/OBXQ9477","article-title":"Research progress of autophagy in heart failure","volume":"16","author":"Li","year":"2024","journal-title":"Am J Transl Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"156187","DOI":"10.1016\/j.phymed.2024.156187","article-title":"Huangqi-Danshen decoction improves heart failure by regulating pericardial adipose tissue derived extracellular vesicular miR-27a-3p to activate AMPK\u03b12 mediated mitophagy","volume":"135","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s12013-024-01268-y","article-title":"miR-1268a regulates fatty acid metabolism by targeting CD36 in angiotensin II-induced heart failure","volume":"82","author":"Xu","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"B104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.12122\/j.issn.1673-4254.2025.01.06","article-title":"Differential expressions of exosomal miRNAs in patients with chronic heart failure and hyperuricemia: diagnostic values of miR-27a-5p and miR-139-3p","volume":"45","author":"Chen","year":"2025","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B105","doi-asserted-by":"publisher","first-page":"180","DOI":"10.32725\/jab.2023.024","article-title":"Ginsenoside Rb2 improves heart failure by down-regulating miR-216a-5p to promote autophagy and inhibit apoptosis and oxidative stress","volume":"21","author":"Peng","year":"2023","journal-title":"J Appl Biomed"},{"key":"B106","doi-asserted-by":"publisher","first-page":"114172","DOI":"10.1016\/j.intimp.2025.114172","article-title":"Role of METTL14 in cardiomyocyte pyroptosis in mice with heart failure by regulating miR-221-3p RNA methylation","volume":"149","author":"Cao","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcdd10010019","article-title":"Inflammation and heart failure: searching for the enemy-reaching the entelechy","volume":"10","author":"Paraskevaidis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/cells14141117","article-title":"The role of inflammation in the pathophysiology of heart failure","volume":"14","author":"Amara","year":"2025","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1161\/01.cir.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.cir.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2020.11.044","article-title":"Etiology-dependent impairment of diastolic cardiomyocyte calcium homeostasis in heart failure with preserved ejection fraction","volume":"77","author":"Frisk","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1152\/physiol.00021.2012","article-title":"No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium","volume":"27","author":"Louch","year":"2012","journal-title":"Physiology (Bethesda)"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1868974","DOI":"10.1155\/2020\/1868974","article-title":"The protective effect of qishen granule on heart failure after myocardial infarction through regulation of calcium homeostasis","volume":"2020","author":"Yang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e1005906","DOI":"10.1371\/journal.pcbi.1005906","article-title":"A model for cooperative gating of L-type Ca2+ channels and its effects on cardiac alternans dynamics","volume":"14","author":"Sato","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCRESAHA.118.313916","article-title":"SPEG controls calcium reuptake into the sarcoplasmic reticulum through regulating SERCA2a by its second kinase-domain","volume":"124","author":"Quan","year":"2019","journal-title":"Circ Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.117.312117","article-title":"LncRNA ZFAS1 as a SERCA2a inhibitor to cause intracellular Ca(2+) overload and Contractile dysfunction in a mouse model of myocardial infarction","volume":"122","author":"Zhang","year":"2018","journal-title":"Circ Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"113806","DOI":"10.1016\/j.yexcr.2023.113806","article-title":"Mechanism of lncRNA HOTAIR in attenuating cardiomyocyte pyroptosis in mice with heart failure via the miR-17-5p\/RORA axis","volume":"433","author":"He","year":"2023","journal-title":"Exp Cell Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"655","DOI":"10.5114\/aoms.2020.96345","article-title":"Emodin improves the cardiac function in the rats with chronic heart failure through regulation of the miR-26b-5p\/PTEN pathway","volume":"20","author":"Gu","year":"2024","journal-title":"Arch Med Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13019-024-02750-7","article-title":"Diagnostic and prognostic value of plasma miR-106a-5p levels in patients with acute heart failure","volume":"19","author":"Fei","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B122","doi-asserted-by":"publisher","first-page":"119959","DOI":"10.1016\/j.jep.2025.119959","article-title":"Network pharmacology and bioinformatics analysis reveals: NXC improves cardiac lymphangiogenesis through miR-126-3p\/SPRED1 regulating the VEGF-C axis to ameliorate post-myocardial infarction heart failure","volume":"350","author":"Xu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1166\/mex.2023.2426","article-title":"MiR-155 regulates macrophage polarization and alleviates myocardial fibrosis through paracrine secretion of transforming growth factor-beta 1 in ischemic heart failure","volume":"13","author":"Zhao","year":"2023","journal-title":"Mater Express"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.4314\/tjpr.v22i8.6","article-title":"MiR-208a reduces inflammatory responses in heart failure rats through \u03b2-catenin pathway","volume":"22","author":"Song","year":"2023","journal-title":"Trop J Pharm Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"208","DOI":"10.14715\/cmb\/2022.68.4.25","article-title":"Effects of MiR-214-3p regulation of SERCA2a expression on contractility of cardiomyocytes in heart failure model","volume":"68","author":"Hu","year":"2022","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13019-024-02628-8","article-title":"miR-200b-3p relieved inflammation in patients with heart failure by regulating ZEB1 expression","volume":"19","author":"Wei","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1701776","DOI":"10.3389\/fimmu.2026.1701776","article-title":"Integrated spatial transcriptomics and single-cell RNA sequencing reveal Lars2-mediated spatiotemporal dynamics of myocardial remodeling in a mouse model of transverse aortic constriction","volume":"17","author":"Ni","year":"2026","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/ijms27020601","article-title":"Insights into cardiomyocyte regeneration from screening and transcriptomics approaches","volume":"27","author":"Fuller","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B129","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/life16030400","article-title":"MicroRNAs in heart failure pathogenesis and progression: mechanistic control, biomarker potential, and translational perspectives","volume":"16","author":"Zivalj","year":"2026","journal-title":"Life (Basel)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1677797","DOI":"10.3389\/fgene.2025.1677797","article-title":"Non-coding RNAs in heart failure: epigenetic regulatory mechanisms and therapeutic potential","volume":"16","author":"Ren","year":"2025","journal-title":"Front Genet"},{"key":"B131","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/st9.0000000000000040","article-title":"Improvement of myocardial fibrosis injury by Shengmai injection in ischemia-induced heart failure in a rat model","volume":"2","author":"Ding","year":"2024","journal-title":"Sci Tradit Chin Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1369642","DOI":"10.3389\/fcvm.2024.1369642","article-title":"Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives","volume":"11","author":"Guo","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/st9.0000000000000044","article-title":"Intervention effects of Naoxintong capsules on psychological and cardiac status in depressed rats after heart failure","volume":"2","author":"Zhao","year":"2024","journal-title":"Sci Tradit Chin Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5937\/jomb0-54440","article-title":"Traditional Chinese medicine as an adjunctive therapy improves cardiac function and reduces serum inflammatory markers in patients with chronic heart failure","volume":"44","author":"Zheng","year":"2025","journal-title":"J Med Biochem"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1753834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:54:27Z","timestamp":1780462467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1753834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":134,"alternative-id":["10.3389\/fcvm.2026.1753834"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1753834","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1753834"}}